Serum Interleukin-33 is a Novel Predictive Biomarker of Hemorrhage Transformation and Outcome in Acute Ischemic Stroke

被引:17
|
作者
Chen, Zhenlei [1 ,2 ]
Hu, Qingzhe [1 ,2 ]
Huo, Yingchao [1 ,2 ]
Zhang, Rongrong [1 ,2 ]
Fu, Qing [1 ,2 ]
Qin, Xinyue [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China
[2] Chongqing Key Lab Neurobiol, 1 Youyi Rd, Chongqing, Peoples R China
来源
关键词
acute ischemic stroke; biomarker; hemorrhage transformation; IL-33; outcome; IL-33; INFARCTION; DISEASE; LEVEL; RISK; ST2;
D O I
10.1016/j.jstrokecerebrovasdis.2020.105506
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Introduction: Hemorrhage Transformation (HT) in acute ischemic stroke (AIS) depends on multiple factors. Some studies have shown that serum interleukin-33 (IL-33) is of central significance as a neuroprotective factor. However, the relationship between serum IL-33 and HT in AIS has not been evaluated. Objective: To investigate the relationship between serum IL-33 concentration and HT in AIS. Methods: We recruited 151 consecutive non-thrombolytic patients with AIS clinically diagnosed in The First Affiliated Hospital of Chongqing Medical University from December 2018 to October 2019. If the patients showed radiographic presentation of HT within two weeks following admission, they were assigned to the HT group; others were assigned to the non-HT group. There were 40 healthy control subjects recruited during the same period. Serum IL-33 concentration was detected by ELISA and the independent risk value of HT in AIS was predicted by multivariate logistic regression. The accuracy was analyzed by receiver operating characteristic (ROC) curves. In three months after admission, the functional outcome was measured by modified Rankin scale (mRS). Results: ROC curve showed that the area under the curve (AUC) of serum IL-33 was 0.739 (95% CI: 0.657-0.821, P < .001) in predicting HT in AIS. When serum IL-33 concentration was <= 67.66 ng/L, the sensitivity and specificity of the prediction were 81.3% and 63%, respectively. Multivariate logistic regression analysis showed that serum IL-33 concentration <= 67.66 ng/L was an independent predictor of HT in AIS (OR = 5.773, 95% CI: 1.685-19.792, P = .005). The follow-up results of mRS showed a higher probability of an unfavorable outcome in those with HT compared to those without HT (OR = 6.520, 95% CI: 2.530-16.803, P < .001). Conclusions: HT in AIS is negatively correlated with outcome. Furthermore, serum IL-33 is an independent predictive biomarker of HT and outcome in AIS.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Predictive value of low serum interleukin-33 levels in acute ischemic stroke outcomes
    Liu, Wei
    Luo, Dongliang
    Liu, Xingyu
    Zhang, Yuqing
    Wang, Zhong
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [2] Serum Interleukin-33 is a Predictor of Depression in Patients with Acute Ischemic Stroke
    Chen, Zhenlei
    Zhang, Rongrong
    Wu, Yanping
    Fu, Qing
    Qin, Xinyue
    CURRENT NEUROVASCULAR RESEARCH, 2021, 17 (05) : 719 - 724
  • [3] Serum interleukin-33 as a novel marker for long-term prognosis and recurrence in acute ischemic stroke patients
    Li, Xian-Mei
    Wang, Xiao-yang
    Feng, Xiao-Wen
    Shao, Meng-Meng
    Liu, Wen-Fang
    Ma, Qin-Qin
    Wang, En-Pei
    Chen, Jie
    Shao, Bei
    BRAIN AND BEHAVIOR, 2019, 9 (09):
  • [4] Serum IL-33 Is a Novel Diagnostic and Prognostic Biomarker in Acute Ischemic Stroke
    Li, Qian
    Lin, Yuanshao
    Huang, Wensi
    Zhou, Yulei
    Chen, Xiaoli
    Wang, Brian
    Zhang, Wanli
    Cai, Zhengyi
    Xue, Jie
    Zhang, Wenhui
    Yu, Tieer
    Wang, Hong
    He, Jincai
    Jin, Kunlin
    Shao, Bei
    Aging and Disease, 2016, 7 (05): : 614 - 622
  • [5] Predictive value of serum transthyretin for outcome in acute ischemic stroke
    Ambrosius, Wojciech
    Michalak, Slawomir
    Kazmierski, Radoslaw
    Andrzejewska, Natalia
    Kozubski, Wojciech
    PLOS ONE, 2017, 12 (06):
  • [6] Serum Interleukin-33 as a Biomarker in Predicting Neonatal Sepsis in Premature Infants
    Halil, Halit
    Tayman, Cuneyt
    Buyuktiryaki, Mehmet
    Okur, Nilufer
    Cakir, Ufuk
    Serkant, Utku
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2018, 21 (07) : 510 - 515
  • [7] Clinical Value of Serum Interleukin-33 Biomarker in Infants With Neonatal Cholestasis
    Behairy, Ola G.
    Elsadek, Akram E.
    Behiry, Eman G.
    Elhenawy, Ibrahim A.
    Shalan, Naglaa H.
    Sayied, Kamal R.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2020, 70 (03): : 344 - 349
  • [8] Serum omentin-1 is a novel biomarker for predicting the functional outcome of acute ischemic stroke patients
    Xu, Tian
    Zuo, Peng
    Wang, Yuqin
    Gao, Zhiwei
    Ke, Kaifu
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (02) : 350 - 355
  • [9] Serum free hemoglobin as a novel potential biomarker for acute ischemic stroke
    Huang, Poyin
    Lo, Li-Hua
    Chen, Yin-Chun
    Lin, Ruey-Tay
    Shiea, Jentaie
    Liu, Ching-Kuan
    JOURNAL OF NEUROLOGY, 2009, 256 (04) : 625 - 631
  • [10] Serum free hemoglobin as a novel potential biomarker for acute ischemic stroke
    Poyin Huang
    Li-Hua Lo
    Yin-Chun Chen
    Ruey-Tay Lin
    Jentaie Shiea
    Ching-Kuan Liu
    Journal of Neurology, 2009, 256 : 625 - 631